# FDA Warning Letter: TJA Health, LLC
> 2024-09-17 · Division of Pharmaceutical Quality Operations III · `2c1ff5c4f331752c`
## Letter
- **Company:** TJA Health, LLC
- **Posted Date:** 2024-09-17
- **Letter Issue Date:** 2024-07-17
- **Issuing Office:** Division of Pharmaceutical Quality Operations III
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*